Ep evl 1/2chmb trnsvns cvdfb
CPT 93642 covers an electrophysiologic evaluation of one or two heart chambers performed through a vein, including cardioversion (restoring normal heart rhythm) when needed. This diagnostic test helps doctors identify and treat abnormal heart rhythms.
This calculator gives a typical-case estimate using standard Medicare modifier rules. Actual payment depends on payer policies, documentation, code-specific CMS status indicators, and locality. Verify before billing.
RVU breakdown
Conversion factor: 32.3465 · Source: CMS MPFS RVU25A · Confidence: High
NCCI bundling edits
Loading bundling edits…
Billing tips
Verify chamber count precisely before coding - 93642 covers one or two chambers only; three or more chambers requires different code (93653)
Impact: Incorrect chamber counting results in $150-300 payment variance and high audit risk; review catheter placement documentation carefully
Document cardioversion capability even if not performed - equipment setup and monitoring for potential cardioversion is inherent to 93642
Impact: Lack of cardioversion documentation can trigger downcoding to basic EP study codes with 30-40% reduction in reimbursement
Bill modifier 26 in hospital settings where facility owns equipment to avoid overpayment recovery; global billing only appropriate in physician-owned labs
Impact: Incorrect global billing versus component billing can result in $150+ overpayment subject to recoupment and potential fraud investigation
Separate diagnostic EP study (93642) from ablation procedures when both performed same session; use modifier 59 if medically necessary and distinct
Impact: Proper separation can preserve full reimbursement for both procedures ($316.67 + ablation fee) versus bundled denial
Ensure pre-procedure timeout, consent, and medical necessity documentation explicitly states indication for transvenous study versus non-invasive testing
Impact: Missing medical necessity justification is leading denial reason, delaying or preventing entire $316.67 payment
Code venous access separately (36010, 36011) only when not included in standard transvenous approach; most payers consider access bundled
Unbundling venous access inappropriately risks compliance flags; proper bundling avoids $50-75 denial and audit triggers
Real billers contribute denial patterns and appeal strategies for this code. Once 5+ reports come in, you’ll see live aggregated data here — the only place this exists, free.
Get the free Revenue Protection Toolkit — the denial triggers, modifier pitfalls, and bundling conflicts that quietly cost you reimbursement. Instant download.
Help build the field knowledge
MedPayIQ gets smarter as billers contribute. If you've had this code denied, share what happened so others learn from it. Anonymous, no patient info.